Because emotional stress is also a frequent trigger of attacks, interrupting upstream kallikrein activity plausibly reduces both physiologic (kinin-mediated) and psychophysiologic (anticipatory anxiety) drivers of dysautonomia, which in turn can translate into better quality of life [34]. The gene discussed is KLK4; the disease is dysautonomia.